Autosomal Dominant Polycystic Kidney: Clinical Trials

4 trials for Autosomal Dominant Polycystic Kidney, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Active not recruiting 2, Completed 1, Unknown 1

Follow Autosomal Dominant Polycystic Kidney: new trials by email Literature Review of Autosomal Dominant Polycystic Kidney trials Research Report on Autosomal Dominant Polycystic Kidney

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD)
Empagliflozin 10 MG, Placebo - Autosomal Dominant Polycystic Kidney
Phase 4Active not recruitingHannover Medical School442024-06-142025-11-24
Treatment of Vascular Stiffness in ADPKD
Sodium chloride (NaCl), Placebo, Amiloride Hcl 5mg Tab - Autosomal Dominant Polycystic Kidney
Phase 4CompletedErasmus Medical Center462022-03-112025-08-17
Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease
Tolvaptan - Autosomal Dominant Polycystic Kidney
Phase 4UnknownLisbet Brandi902018-09-122018-11-26
Statin Therapy in Patients With Early Stage ADPKD
Pravastatin, Placebo - ADPKD, Autosomal Dominant Polycystic Kidney
Phase 4Active not recruitingUniversity of Colorado, Denver1502017-08-312025-05-08

Narrower conditions

Polycystic Kidney, Autosomal Dominant (4)  ·  Hypertension (1)  ·  Polycystic Kidney Diseases (1)

Broader conditions

Abnormalities, Multiple (4)  ·  Ciliopathies (4)  ·  Congenital Abnormalities (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genetic Diseases, Inborn (4)  ·  Kidney Diseases (4)  ·  Kidney Diseases, Cystic (4)  ·  Male Urogenital Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Polycystic Kidney Diseases (3)  ·  Cardiovascular Diseases (1)  ·  Vascular Diseases (1)

Interventions

Amiloride (1)  ·  Pravastatin (1)  ·  Sodium Chloride (1)  ·  Sodium Chloride, Dietary (1)  ·  Tolvaptan (1)  ·  empagliflozin (1)

Sponsors

Erasmus Medical Center (1)  ·  Hannover Medical School (1)  ·  Lisbet Brandi (1)  ·  University of Colorado, Denver (1)

Countries

Denmark (1)  ·  Germany (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Lisbet Brandi, MD DMSc MHM (1)  ·  M. Salih, MD, PhD (1)  ·  Michel Chonchol, MD (1)

Results publications

PMID 39356039, PMID 38151173, PMID 39675824, PMID 40377984, PMID 41077128

NIH funding

2023 (1)